Bacteriophage attachment to the somatic antigen of salmonella: effect of o-specific structures in leaky R mutants and s, t1 hybrids.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 16557701)

Published in Infect Immun on January 01, 1970

Authors

A A Lindberg1, M Sarvas, P H Mäkelä

Author Affiliations

1: Department of Bacteriology, Statens Bakteriologiska Laboratorium, Stockholm, Sweden.

Articles citing this

Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium. Infect Immun (1971) 1.62

Partition of Salmonella typhimurium in a two-polymer acqueous phase system in relation to liability to phagocytosis. Infect Immun (1973) 1.61

Bacteriophage attachment sites, serological specificity, and chemical composition of the lipopolysaccharides of semirough and rough mutants of Salmonella typhimurium. J Bacteriol (1971) 1.33

Genomic and biological analysis of phage Xfas53 and related prophages of Xylella fastidiosa. J Bacteriol (2010) 1.06

Interaction of Pseudomonas bacteriophage 2 with the slime polysaccharide and lipopolysaccharide of Pseudomonas aeruginosa strain B1. J Virol (1971) 1.03

Biosynthesis of T1 antigen in Salmonella: origin of D-galactofuranose and D-ribofuranose residues. J Bacteriol (1971) 1.00

Genetic transfer of Salmonella typhimurium and Escherichia coli lipopolysaccharide antigens to Escherichia coli K-12. J Bacteriol (1972) 0.96

Salmonellosis in Indonesia: phage-type of Salmonella oranienburg obtained from hospitalized patients in Jakarta, Indonesia. J Hyg (Lond) (1981) 0.95

Contributions of P2- and P22-like prophages to understanding the enormous diversity and abundance of tailed bacteriophages. Virology (2016) 0.85

T2 lipopolysaccharide antigen of Salmonella: genetic determination of T2 and properties of the T2, T2,S, and T2,SR Forms. Infect Immun (1976) 0.80

T2 lipopolysaccharide antigen of Salmonella: comparison of the properties of T2 and mucoid forms. Infect Immun (1976) 0.76

Articles cited by this

Genetic exchange in Salmonella. J Bacteriol (1952) 23.68

Lysogenization and superinfection immunity in Salmonella. Virology (1958) 4.80

ROUGH MUTANTS OF SALMONELLA TYPHIMURIUM. I. GENETICS. Nature (1964) 3.98

Metabolism and cell wall structure of a mutant of Salmonella typhimurium deficient in phosphoglucose isomerase. Biochem Biophys Res Commun (1963) 3.81

Extended deletions in the histidine-rough-B region of the Salmonella chromosome. Proc Natl Acad Sci U S A (1967) 3.51

SEMIROUGH STRAINS OF SALMONELLA. Proc Natl Acad Sci U S A (1965) 3.26

ROUGH MUTANTS OF SALMONELLA TYPHIMURIUM. II. SEROLOGICAL AND CHEMICAL INVESTIGATIONS. Nature (1964) 2.88

Transduction by bacteriophage P22 in nonsmooth mutants of Salmonella typhimurium. J Bacteriol (1967) 2.78

Localization of Somatic Antigen on Gram-Negative Bacteria by Electron Microscopy. J Bacteriol (1965) 2.75

The morphologic structure of isolated bacterial lipopolysaccharide. J Mol Biol (1967) 2.69

Genomic masking and recombination between serologically unrelated phages P22 and P221. Virology (1961) 2.51

Genetics and cultural properties of mutants of Salmonella typhimurium lacking glucosyl or galactosyl lipopolysaccharide transferases. Nature (1968) 1.73

Studies of a receptor for felix O-1 phage in Salmonella minnesota. J Gen Microbiol (1967) 1.71

Influence of O side chains on the attachment of the Felix O-1 bacteriophage to Salmonella bacteria. J Bacteriol (1969) 1.46

A new antigen of Salmonella paratyphi B and Salmonella typhi murium. Acta Pathol Microbiol Scand (1956) 1.35

Structure of cell wall lipopolysaccharide from Salmonella typhimurium. I. Linkage between o side chains and R core. J Biol Chem (1969) 1.22

Biosynthesis of O-antigenic polysaccharides in Salmonella. Ann N Y Acad Sci (1966) 1.07

Immunochemical studies on T1,S hybrids of Salmonella paratyphi--B. Ann Med Exp Biol Fenn (1967) 0.96

Inheritance of Salmonella T1 antigen. Ann Med Exp Biol Fenn (1967) 0.95

The production, by recombination, of Salmonella forms with both T-1 and O specifities. Acta Pathol Microbiol Scand (1965) 0.90

The structure of bacteriophage phi R. J Gen Microbiol (1962) 0.89

[Structure of bacteriophages responsible for conversion phenomena in Salmonella]. Ann Inst Pasteur (Paris) (1965) 0.89

Articles by these authors

Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01

Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56

Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Eur J Biochem (1980) 8.05

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59

Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05

Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01

F + , Hfr, and F' strains of Salmonella typhimurium and Salmonella abony. Bacteriol Rev (1972) 3.73

P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50

Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet (1982) 3.39

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med (1984) 3.37

Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83

Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79

Handling of scientific dishonesty in the Nordic countries. National Committees on Scientific Dishonesty in the Nordic Countries. Lancet (1999) 2.66

Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infect Immun (1979) 2.53

Effect of polymyxin on the ultrastructure of the outer membrane of wild-type and polymyxin-resistant strain of Salmonella. J Bacteriol (1976) 2.43

Enterobacterial common antigen. Bacteriol Rev (1976) 2.41

Nucleotide sequence of the promoter and NH2-terminal signal peptide region of the alpha-amylase gene from Bacillus amyloliquefaciens. Gene (1981) 2.30

The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science (1983) 2.22

Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis (1996) 2.15

Transcription and translation of foreign genes in Bacillus subtilis by the aid of a secretion vector. J Bacteriol (1985) 2.08

Bacteriophage-resistant mutants of Salmonella typhimurium deficient in two major outer membrane proteins. J Bacteriol (1976) 2.02

Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet (1975) 1.97

A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91

Risk factors for pneumonia in the elderly. Am J Med (1994) 1.89

The role of IFN-gamma in murine Salmonella typhimurium infection. Microb Pathog (1990) 1.84

Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium. J Bacteriol (1979) 1.82

Genetic determination of the O antigens of Salmonella groups B (4,5,12) and C1(6,7). J Bacteriol (1966) 1.81

Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80

Formation of protein micelles from amphiphilic membrane proteins. Proc Natl Acad Sci U S A (1978) 1.80

Inheritance of the O antigens of Salmonella groups B and D. J Gen Microbiol (1965) 1.79

New Salmonella typhimurium mutants with altered outer membrane permeability. J Bacteriol (1984) 1.76

Secretion of Escherichia coli beta-lactamase from Bacillus subtilis by the aid of alpha-amylase signal sequence. Proc Natl Acad Sci U S A (1982) 1.74

Bacillus licheniformis penicillinase synthesized in Escherichia coli contains covalently linked fatty acid and glyceride. Proc Natl Acad Sci U S A (1981) 1.71

Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid. J Biol Chem (1985) 1.71

A novel virulence-associated cell surface structure composed of 47-kd protein subunits in Yersinia enterocolitica. EMBO J (1985) 1.68

Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin. Mol Microbiol (1993) 1.66

Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics (1984) 1.65

The PrsA lipoprotein is essential for protein secretion in Bacillus subtilis and sets a limit for high-level secretion. Mol Microbiol (1993) 1.65

Genetic aspects of biosynthesis and structure of Salmonella somatic polysaccharide. Ann N Y Acad Sci (1966) 1.64

An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. J Immunol (1984) 1.62

Membrane-bound and secreted forms of penicillinase from Bacillus licheniformis. J Mol Biol (1978) 1.62

Mutants defective in the 33K outer membrane protein of Salmonella typhimurium. J Bacteriol (1979) 1.60

The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis (1981) 1.59

Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J (1998) 1.59

Genetic determination of enzymes synthesizing O-specific sugars of Salmonella lipopolysaccharides. J Bacteriol (1966) 1.58

Role of O-antigen (lipopolysaccharide) factors in the virulence of Salmonella. J Infect Dis (1973) 1.57

Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53

Participation of lipopolysaccharide genes in the determination of the enterobacterial common antigen: analysis of R mutants of Salmonella minnesota. J Bacteriol (1974) 1.52

Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52

A novel two-component regulatory system in Bacillus subtilis for the survival of severe secretion stress. Mol Microbiol (2001) 1.50

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med (1997) 1.50

Protein K: a new major outer membrane protein found in encapsulated Escherichia coli. J Bacteriol (1979) 1.47

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis (2001) 1.47

Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol (1982) 1.45

The role of lipoprotein processing by signal peptidase II in the Gram-positive eubacterium bacillus subtilis. Signal peptidase II is required for the efficient secretion of alpha-amylase, a non-lipoprotein. J Biol Chem (1999) 1.45

D-Alanine substitution of teichoic acids as a modulator of protein folding and stability at the cytoplasmic membrane/cell wall interface of Bacillus subtilis. J Biol Chem (2000) 1.44

Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus. Infect Immun (1984) 1.41

Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model. Microb Pathog (1986) 1.40

Mutant of Escherichia coli K-12 defective in D-glucosamine biosynthesis. J Bacteriol (1971) 1.40

Immunization with major outer membrane protein (porin) preparations in experimental murine salmonellosis: effect of lipopolysaccharide. Infect Immun (1981) 1.40

Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. J Immunol (1997) 1.39

Triggering infections in reactive arthritis. Ann Rheum Dis (1985) 1.36

Antigenic properties of Chlamydia trachomatis lipopolysaccharide. Infect Immun (1985) 1.34

Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun (1983) 1.34

Genetic determination of bacterial virulence, with special reference to Salmonella. Curr Top Microbiol Immunol (1986) 1.34

Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis. Infect Immun (1975) 1.32

Presence of rfe genes in Escherichia coli: their participation in biosynthesis of O antigen and enterobacterial common antigen. J Bacteriol (1976) 1.32

Participation of lipopolysaccharide genes in the determination of the entobacterial common antigen: analysis in Salmonella groups B and C1. J Bacteriol (1974) 1.32

rfaP mutants of Salmonella typhimurium. Eur J Biochem (1989) 1.31

Pneumococcal vaccine and otitis media. Lancet (1980) 1.31

Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis (1981) 1.27

A gene (prsA) of Bacillus subtilis involved in a novel, late stage of protein export. Mol Microbiol (1991) 1.26

Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med (1999) 1.26

A precursor form of the penicillinase from Bacillus licheniformis. FEBS Lett (1978) 1.24

The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J Infect (1987) 1.24

Structural investigations on the core polysaccharide of Escherichia coli 0100. Eur J Biochem (1971) 1.24

Bacillus subtilis PrsA is required in vivo as an extracytoplasmic chaperone for secretion of active enzymes synthesized either with or without pro-sequences. Mol Microbiol (1993) 1.22

Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22

Enterobacterial common antigen in rfb deletion mutants of Salmonella typhimurium. J Bacteriol (1976) 1.22

Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis (1986) 1.22

Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet (1982) 1.21

Asymmetric and symmetric membrane reconstitution by detergent elimination. Studies with Semliki-Forest-virus spike glycoprotein and penicillinase from the membrane of Bacillus licheniformis. Eur J Biochem (1981) 1.21

Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J (1989) 1.20

Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr Infect Dis J (1989) 1.20

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine (1999) 1.19

The smooth lipopolysaccharide character of 1,4,(5),12 and 1,9,12 transductants formed as hybrids between groups B and D of salmonella. Eur J Biochem (1971) 1.19

Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis (1976) 1.19

First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis (1986) 1.18

Lipid modification of prelipoproteins is dispensable for growth but essential for efficient protein secretion in Bacillus subtilis: characterization of the Lgt gene. Mol Microbiol (1999) 1.16

Quantitation of the capacity of the secretion apparatus and requirement for PrsA in growth and secretion of alpha-amylase in Bacillus subtilis. J Bacteriol (2001) 1.16

Glucosylation of lipopolysaccharide in Salmonella: biosynthesis of O antigen factor 12 2 . I. Over-all reaction. J Biol Chem (1971) 1.14

Biosynthesis of uridine diphosphate N-acetylmannosaminuronic acid in rff mutants of Salmonella tryphimurium. J Bacteriol (1978) 1.14

How genes determine the structure of the Salmonella lipopolysaccharide. J Gen Microbiol (1969) 1.13

Mutants of Bacillus subtilis defective in protein export. J Gen Microbiol (1988) 1.13